Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice
Chunrong Li, James C. Romero-Masters, Shane M. Huebner, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 6, pp. e1008590-e1008590
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Epstein-Barr virus: Biology and clinical disease
Blossom Damania, Shannon C. Kenney, Nancy Raab‐Traub
Cell (2022) Vol. 185, Iss. 20, pp. 3652-3670
Open Access | Times Cited: 247
Epstein-Barr Virus and Neurological Diseases
Nan Zhang, Yuxin Zuo, Liping Jiang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 98
EBV and Lymphomagenesis
Daniel Sausen, Ayeman Basith, Syed Muqeemuddin
Cancers (2023) Vol. 15, Iss. 7, pp. 2133-2133
Open Access | Times Cited: 27
A metabolic dependency of EBV can be targeted to hinder B cell transformation
Bojana Müller-Durovic, J. Jäger, Christine Engelmann, et al.
Science (2024) Vol. 385, Iss. 6704
Closed Access | Times Cited: 17
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 12
Epigenetic control of the Epstein-Barr lifecycle
Rui Guo, Benjamin E. Gewurz
Current Opinion in Virology (2021) Vol. 52, pp. 78-88
Open Access | Times Cited: 38
The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases
Linlin Zhang, Ran Wang, Zhengde Xie
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 12, pp. 4413-4426
Open Access | Times Cited: 27
Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
Aisling M. Ross, Ciara I. Leahy, Fiona Neylon, et al.
Life (2023) Vol. 13, Iss. 2, pp. 521-521
Open Access | Times Cited: 14
Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
Eric Burton, Benjamin E. Gewurz
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010254-e1010254
Open Access | Times Cited: 22
Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma
Qian‐Ying Zhu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Association between Epstein‐Barr virus LMP‐1 and Hodgkin lymphoma LMP‐1 mechanisms in Hodgkin lymphoma development
Leonam Oliver Durval Oliveira, Igor Brasil Costa, Juarez Antônio Simões Quaresma
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 4
Viral oncogenesis in cancer: from mechanisms to therapeutics
Qing Xiao, Yi Liu, Tingting Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Differential carbonic anhydrase activities control EBV-induced B-cell transformation and lytic cycle reactivation
Samaresh Malik, Joyanta Biswas, Purandar Sarkar, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1011998-e1011998
Open Access | Times Cited: 3
Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future
Marc Bienz, S. Ramdani, Hans Knecht
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6623-6623
Open Access | Times Cited: 18
Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies
Priya Saikumar Lakshmi, Cliff I. Oduor, Catherine S. Forconi, et al.
Life Science Alliance (2023) Vol. 6, Iss. 5, pp. e202101355-e202101355
Open Access | Times Cited: 6
Immune Escape by Non-coding RNAs of the Epstein Barr Virus
Christian Münz
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 14
3D-Q-FISH/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/ Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma
Hans Knecht, Photini Petrogiannis-Haliotis, Sherif Louis, et al.
(2024)
Open Access | Times Cited: 1
Epstein–Barr virus lytic replication and cancer
Hao Li, Chih-Ying Lee, Henri‐Jacques Delecluse
Current Opinion in Virology (2024) Vol. 70, pp. 101438-101438
Open Access | Times Cited: 1
Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review
Kuangguo Zhou, Duanhao Gong, Yunfeng Han, et al.
Annals of Hematology (2023) Vol. 103, Iss. 7, pp. 2207-2213
Closed Access | Times Cited: 3
Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
Patrick Schuhmachers, Christian Münz
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 4
Exploring the Genetic Diversity of Epstein–Barr Virus among Patients with Gastric Cancer in Southern Chile
María Elena Reyes, Louise Zanella, Ismael Riquelme, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11276-11276
Open Access | Times Cited: 1
3D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma
Hans Knecht, Tina Petrogiannis‐Haliotis, Sherif Louis, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1748-1748
Open Access
The novel immune landscape of immune‐checkpoint blockade in EBV‐associated malignancies
Feng Zhang, Wenjing Li, Xinglong Zheng, et al.
The FASEB Journal (2024) Vol. 38, Iss. 21
Closed Access
Molecular Pathogenesis of Hodgkin’s Lymphoma: Advances Through the Key Player LMP1 and 3D Nanotechnology
Bassem Sawan, Tina Petrogiannis‐Haliotis, Hans Knecht
(2022), pp. 177-200
Closed Access | Times Cited: 2
Evaluation of Role of Hepatitis C Virus in the Pathogenesis of Hodgkin Lymphoma Patients
Hadi Meeran Hussain, Manzar Zakaria, Qasim Raza, et al.
(2023) Vol. 17, Iss. 2, pp. 392-394
Open Access
Page 1 - Next Page

Scroll to top